Items Tagged ‘Chronic Lymphoblastic Leukemia’

May 20, 2019

Calquence Improves Survival in Relapsed Chronic Lymphocytic Leukemia

By

An interim analyses of the phase 3 “ASCEND” clinical trial evaluating single-agent Calquence (acalabrutinib) compared to Rituxan (rituximab) plus idelasib or bendamustine in recurrent chronic lymphocytic leukemia (CLL) is closed early due to favorable results. (1) About chronic lymphocytic leukemia CLL is the most common type of leukemia in adults. (2) with an average age […]

View full entry

Tags: Chronic Lymphoblastic Leukemia, Genetics, germline mutations, Hereditary Caner Test, hereditary risk, Leukemia, myRisk, News, Prostate Cancer


December 11, 2008

Treanda® and Rituxan® Effective for Relapsed CLL

By

Treanda® and Rituxan® Effective for Relapsed CLL In a Phase II clinical trial, the combination of Treanda® (bendamustine)®and Rituxan® (rituximab)®produced promising results among patients with relapsed chronic lymphocytic leukemia (CLL). These results were presented at the 50th Annual Meeting of the American Society of Hematology. CLL is a disease characterized by high numbers of circulating […]

View full entry

Tags: Chronic Lymphoblastic Leukemia